Lifeboat Foundation

Staff members who die will be put in cold storage until medical science can revive them.

Since congressional Republicans voted in a bill containing the Trump administration’s roll back of the Affordable Care Act, healthcare is once again a topic on everyone’s lips. In the absence of any universal healthcare scheme, employer-provided medical coverage is a crucial benefit for employees, tempting people to stay at jobs they might otherwise have left, or apply for positions they wouldn’t otherwise consider.

In the contest to attract new hires, tech companies often supplement already generous salaries with comprehensive benefit packages, and in this vein one company has hit on a novel idea: A health plan that covers its employees beyond death and into the realms of a speculative future rebirth.

Continue reading “This AI Company Offers Cryogenic Freezing With Its Health Plan” »

I interview briefly in this new and interesting video on longevity for CBS San Francisco:

A new health assessment is leading the way to give you precise information on how to lead the healthiest, longest life possible. Susie Steimle reports. (5/8/17)

On May 16-19th a longevity research conference is being held in Paris.

On May 16-19th renowned researchers and advocates of healthy life extension will gather in Paris to discuss recent breakthroughs in regenerative medicine. The conference organized by the International Cell Senescence Association (ICSA) “The Ins and Outs of Cellular Senescence: Understanding the Biology to Foster Healthy Aging and Suppression of Disease” will take place in the famous Pasteur Institute in Paris. In addition to the main conference, an open public event will be held on the afternoon of May, 19th: an international panel of experts in aging research under the lead of Eric Gilson (Ircan research institute on cancer and aging in Nice) will reveal what we know about biological aging today and what medicine can do to prevent age-related diseases.

Continue reading “The Ins and Outs of Cellular Senescence: Longevity Conference Paris” »

They plan to record personality, memory, and body function information, and recreate it.

You can see how deep-rooted is the wish of some to just ignore the problem of ageing when they say that rejuvenation won’t happen in time for them, and that there’s thus no reason they should concern themselves with the whole issue. This article on rebuts this meta-objection and discusses its origins.

People’s last line of defence to keep ignoring the problem of ageing and rejuvenation is often the meta-objection ‘it won’t happen in my lifetime’. Let’s have a look at what’s wrong with this reasoning, and why some people think this way.

#aging #crowdfundthecure

Continue reading “Rejuvenaction — Posts” »

The major mouse testing pogram is organizing a special 1.5 hour long longevity panel with Dr. Alexandra Stolzing, Dr. Aubrey de Grey and other guests in early June. This was one of the rewards for their campaign on Lifespan.io last year.

They are asking the community to suggest questions to ask Dr. Stolzing and Dr. de Grey so head on over there if you would like to ask them something and maybe it will make the show. The show will be broadcast live on Facebook and the dates will be announced shortly.

We hope to lifestream the science panel to facebook in June and will confirm the time and date shortly.

Continue reading “We are currently organizing our Longevity Panel with Alexandra Stolzing, Aubrey de Grey and a number of other guests” »

https://www.youtube.com/watch?v=B-6-T_StYM8

From 2014, a docu focusing on Aubrey and Bill Andrews.

Live forever… or die trying

Continue reading “The Immortalists” »

What are the bottlenecks in developing a rejuvenation biotechnology industry? LEAF takes a look at some of the main problems we are facing in creating that industry.

One of the most frequent questions we get from the general public is when will rejuvenation therapies arrive? Whilst young people can wait for a few more decades, those in middle age are much more concerned. According to statistics, new drug development takes 17 years on average, but the countdown only begins at the moment when the underlying mechanisms are investigated well enough – which cannot be said about the mechanisms of aging.

We have made great progress in understanding aging in the last decade thanks to the march of technology. One solution to an aging process is entering human clinical trials this year: a therapy to remove aged damaged cells to promote tissue repair and reduce chronic inflammation. This is of course fantastic news but progress is still too slow.

Continue reading “Bottlenecks to the Development of Rejuvenation Biotechnology” »

Aubrey de Grey in this new interview with Vox.

We all grow old. We all die.

For Aubrey de Grey, a biogerontologist and chief science officer of the SENS Research Foundation, accepting these truths is, well, not good enough. He decided in his late twenties (he’s currently 54) that he “wanted to make a difference to humanity” and that battling age was the best way to do it. His life’s work is now a struggle against physics and biology, the twin collaborators in bodily decay.

Continue reading “Scientists are waging a war against human aging. But what happens next?” »